Currently, there are 658.64M common shares owned by the public and among those 517.86M shares have been available to trade.
The company’s stock has a 5-day price change of -4.04% and -14.76% over the past three months. CCCS shares are trading -25.15% year to date (YTD), with the 12-month market performance down to -25.47% lower. It has a 12-month low price of $8.14 and touched a high of $12.88 over the same period. CCCS has an average intraday trading volume of 9.02 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.32%, -1.74%, and -16.63% respectively.
Institutional ownership of CCC Intelligent Solutions Holdings Inc (NASDAQ: CCCS) shares accounts for 81.99% of the company’s 658.64M shares outstanding.
It has a market capitalization of $5.79B and a beta (3y monthly) value of 0.73. The stock’s trailing 12-month PE ratio is 618.31, while the earnings-per-share (ttm) stands at $0.01. The company has a PEG of 71.32 and a Quick Ratio of 1.42 with the debt-to-equity ratio at 0.49. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.64% over the week and 3.67% over the month.
Analysts forecast that CCC Intelligent Solutions Holdings Inc (CCCS) will achieve an EPS of 0.08 for the current quarter, 0.09 for the next quarter and 0.41 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.08 while analysts give the company a high EPS estimate of 0.08. Comparatively, EPS for the current quarter was 0.09 a year ago. Earnings per share for the fiscal year are expected to decrease by -3.57%, and 13.51% over the next financial year.
Looking at the support for the CCCS, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on February 26, 2025, with the firm’s price target at $14-$11. Morgan Stanley coverage for the CCC Intelligent Solutions Holdings Inc (CCCS) stock in a research note released on November 13, 2024 offered a Overweight rating with a price target of $15. BofA Securities was of a view on August 20, 2024 that the stock is Buy, while Citigroup gave the stock Neutral rating on December 13, 2023, issuing a price target of $13. Morgan Stanley on their part issued Equal-Weight rating on December 12, 2023.
